Lijing You

This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 1 EPO patent. Top assignee: Altor Bioscience Corporation. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lijing You. Retrieved from https://idiyas.com/inventor/lijing-you

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 7.4

ph-index = 4

Forward Citations = 37(Granted Patents)

Company Filing History:

8 out of 61

Altor Bioscience Corporation

patents

Years Active: 2021-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12233116 - IL-15-based fusions to IL-12 and IL-18 (2025-02-25),

2. 11975059 - IL-15-based fusions to IL-12 and IL-18 (2024-05-07),

3. 11872272 - IL-15-based fusions to IL-12 and IL-18 (2024-01-16),

4. 11612645 - IL-15-based fusions to IL-12 and IL-18 (2023-03-28),

5. 11571470 - IL-15-based fusions to IL-12 and IL-18 (2023-02-07),

6. 11369679 - Multimeric IL-15-based molecules (2022-06-28),

7. 11318201 - Multimeric IL-15-based molecules (2022-05-03),

8. 11129883 - IL-15-based fusions to IL-12 and IL-18 (2021-09-28),

Title: The Innovative Contributions of Inventor Lijing You

Introduction

Lijing You is a prominent inventor based in Miramar, Florida, known for her significant contributions to the field of biomedical innovations. With a total of eight patents, she has been instrumental in developing novel therapeutic solutions that harness the power of specific proteins to target diseases more effectively.

Latest Patents

Among her latest patents are groundbreaking inventions related to IL-15-based fusions to IL-12 and IL-18. These inventions encompass multi-specific fusion protein complexes, where one domain includes IL-15 or its functional variants, paired with a binding domain that is specific to IL-12 or IL-18. This innovative approach could pave the way for more targeted therapies in the treatment of various conditions, showcasing her dedication to advancing medical science.

Career Highlights

Lijing has worked at notable organizations such as Altor Bioscience Corporation and Nantcell, Inc., where she has played a crucial role in pushing the boundaries of current research and development. Her expertise has made a tangible impact in her field, reflecting her commitment to innovation and excellence in scientific research.

Collaborations

Throughout her career, Lijing You has collaborated with esteemed colleagues, including Hing C Wong and Warren Marcus. These partnerships have not only enriched her research but have also contributed to the collective knowledge within the biomedical community, emphasizing the importance of teamwork in fostering innovation.

Conclusion

Lijing You continues to be a driving force in the biomedical field with her inventive spirit and commitment to developing advanced therapies. Her innovative work on IL-15-based fusions exemplifies the potential within the realm of protein therapeutic solutions, promising brighter prospects for medical advancements in the future.

Profile summary based on public USPTO records.